Skip to main content
Log in

Afatinib/cisplatin/pemetrexed

Nausea, vomiting and development of resistance to afatinib: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Qin B-D, et al. The effectiveness of afatinib and osimertinib in a chinese patient with advanced lung adenocarcinoma harboring a rare triple EGFR mutation (R670W/H835L/L833V): A case report and literature review. OncoTargets and Therapy 11: 4739-4745, 10 Aug 2018. Available from: URL: http://doi.org/10.2147/OTT.S167346 - China

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Afatinib/cisplatin/pemetrexed. Reactions Weekly 1737, 17 (2019). https://doi.org/10.1007/s40278-019-57112-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-57112-9

Navigation